|
Some of these posts are very old and might contain outdated information. You may wish to search for newer posts instead.
|
Thayendanegea
quiet walker



Registered: 02/20/12
Posts: 7,596
Loc: 7 Lodges Nation
|
Johns Hopkins study on psilocybin and cancer patients. 2
#23883928 - 12/01/16 08:58 AM (7 years, 1 month ago) |
|
|
I posted this on the news story forum but figured it could do some good here. Science is having success in helping cancer patients to overcome anxiety and depression with the use of psilocybin.
http://www.baltimoresun.com/health/bs-hs-psychedelics-cancer-20161201-story.html
-------------------- Look Deep Into Nature,and Then You Will Understand Everything Better. Albert Einstein
|
Huskies
Boop More Snoots



Registered: 03/22/16
Posts: 1,048
Last seen: 1 day, 1 hour
|
Re: Johns Hopkins study on psilocybin and cancer patients. [Re: Thayendanegea] 1
#23883960 - 12/01/16 09:14 AM (7 years, 1 month ago) |
|
|
They also did one for MDMA and PTSD
http://www.nytimes.com/2016/11/29/us/ptsd-mdma-ecstasy.html
Hopefully these are good signs that these draconian laws might be on their way out. Once Canada and most of the USA legalize weed, I think drug prohibition is going to quickly be on its way out worldwide.
-------------------- I call them Huskies cause you tell them to go "Mush! Mush""
|
Moabfighter
Tam Fighter


Registered: 12/13/15
Posts: 2,710
|
Re: Johns Hopkins study on psilocybin and cancer patients. [Re: Huskies]
#23884005 - 12/01/16 09:29 AM (7 years, 1 month ago) |
|
|
Saw this on front page of yahoo and couldn't believe it was on there. Damn.
Haven't tripped in months. Gonna eat 1.6 today and see what happens.
-------------------- KSSS And PE WBS.
Edited by Moabfighter (12/01/16 09:34 AM)
|
czech
baked like a casserole



Registered: 11/16/16
Posts: 3,099
Loc: pnw
Last seen: 6 years, 3 months
|
Re: Johns Hopkins study on psilocybin and cancer patients. [Re: Thayendanegea]
#23884022 - 12/01/16 09:36 AM (7 years, 1 month ago) |
|
|
If there's any hope for the future, it's in medical research of psychedelic chemicals.
In my opinion and experience, psilocybin has been the longest lasting, most natural, healthy, and easiest method for dealing with depression and anxiety. LSD comes a close second and then MDMA.
My problem with MDMA is that it is indeed neurotoxic and causes mild brain damage.
Psilocybin builds neural pathways and contributed to the higher function of my mind.
|
Nobler Hino
a dojo and a forge?!


Registered: 08/29/15
Posts: 1,780
Loc: Deep Ellum
|
Re: Johns Hopkins study on psilocybin and cancer patients. [Re: czech]
#23884040 - 12/01/16 09:46 AM (7 years, 1 month ago) |
|
|
Nice
--------------------
   "The sacred mushroom takes me by the hand and brings me to the world where everything is known. It is they, the sacred mushrooms, that speak in a way I can understand. I ask them and they answer me.” – Maria Sabina
|
ShroomerInTheRye
Clit Commander



Registered: 01/12/12
Posts: 13,036
Loc: Themyscira
|
Re: Johns Hopkins study on psilocybin and cancer patients. [Re: Thayendanegea]
#23885607 - 12/01/16 07:41 PM (7 years, 1 month ago) |
|
|
For the first time in a very long time, I am hopeful that maybe, just maybe, they can finally unlock the door to the prison cell in my brain. If it weren't for mushrooms last year, I probably would have "opted out" of life. I stopped dosing daily after the new year and felt okay...better than I had in years, actually. My mood stayed better until a series of setbacks in October and November knocked me for a good loop.
I'm paying extra special attention to these studies...specifically dosage and timing. If they can figure out some sort of therapeutic threshold, that would be great.
--------------------
<-- Clicky Clicky
|
DavidReishi
Mediocrity Extraordinaire


Registered: 10/07/15
Posts: 1,333
|
Re: Johns Hopkins study on psilocybin and cancer patients. [Re: Thayendanegea]
#23885618 - 12/01/16 07:43 PM (7 years, 1 month ago) |
|
|
-------------------- Species found in the Bay area: P. allenii, P. cyanescens, P. ovoideocystidiata, P. stuntzii, P. azurescens
|
Matai


Registered: 05/04/14
Posts: 1,016
Loc: NZ
|
Re: Johns Hopkins study on psilocybin and cancer patients. [Re: DavidReishi]
#23885729 - 12/01/16 08:24 PM (7 years, 1 month ago) |
|
|
Cool to hear about. For anyone who's interested and doesn't already know, there's a book called 'Sacred Knowledge' by William Richards, who is/was very involved in the psilocybin research in John Hopkins. I didn't actually think agree with quite a few parts of the book, but it was an interesting read nevertheless.
-------------------- All that we see or seem Is but a dream within a dream
|
PrimalSoup
hyperspatial illuminations



Registered: 11/17/09
Posts: 13,568
Loc: PNW
Last seen: 1 year, 5 months
|
Re: Johns Hopkins study on psilocybin and cancer patients. [Re: Matai]
#23885747 - 12/01/16 08:35 PM (7 years, 1 month ago) |
|
|
Yah, it's nice to see it covered in the mass media. Shrooms negate depression, hardly a news flash though. 
--------------------
if you stand too close to the machine it'll start to eat youPrimal's simple tested teks and projects: Wheat Prep 2.0 Acidic Tea Tek Potency Project!
|
404
error


Registered: 08/20/10
Posts: 14,539
|
Re: Johns Hopkins study on psilocybin and cancer patients. [Re: Thayendanegea]
#23886038 - 12/01/16 10:02 PM (7 years, 1 month ago) |
|
|
Quote:
Thayendanegea said: I posted this on the news story forum but figured it could do some good here. Science is having success in helping cancer patients to overcome anxiety and depression with the use of psilocybin.
http://www.baltimoresun.com/health/bs-hs-psychedelics-cancer-20161201-story.html
Quote:
Psychedelics reduce anxiety, depression in patients, study finds Judith Goedeke Judith Goedeke, a kidney cancer survivor, took part in a study by a team at Johns Hopkins Medicine researching hallucinogens and cancer patients. (Kim Hairston / Baltimore Sun) Andrea K. McDanielsAndrea K. McDanielsContact ReporterThe Baltimore Sun Could psychedelics be the key to emotional distress in cancer patients?
Researchers at the Johns Hopkins University School of Medicine have found that a psychedelic drug can significantly reduce anxiety, depression and other emotional distress in cancer patients.
The patients experienced almost immediate relief, which lasted for months, after taking psilocybin, the active hallucinogenic ingredient in "magic mushrooms," the researchers reported. A separate study by researchers at NYU Langone Medical Center found the same effect.
The findings are the latest in a growing body of research on how psychedelics can be used to treat various illnesses. Studies involving the drugs have resurged in recent years after being stymied for decades when the federal government deemed psychedelics a dangerous controlled substance and stopped funding the research.
The Johns Hopkins and NYU researchers, who published their findings online Thursday in the Journal of Psychopharmacology, called them the most conclusive evidence yet that psychedelics could ease emotional pain and anxiety for cancer patients.
The researchers also said psilocybin has the potential to be used as part of end-of-life care for terminal patients.
A total of 80 patients participated in the two trials. The researchers pointed out that the two studies used different techniques but came to the same conclusion, supporting the validity of the results.
"That gave us even greater confidence there was something powerful going on here," said Roland Griffiths, a professor of behavioral biology and neuroscience at the Johns Hopkins University School of Medicine.
The researchers now plan to apply to the U.S. Food and Drug Administration to undertake a larger clinical trial with hundreds of patients.
In the Hopkins study, 80 percent of the 51 patients who participated continued to show decreased feelings of depression and anxiety about the prospect of dying six months after the final treatment. About 67 percent said the effect of the drug was one of their top five most meaningful life experiences. The Hopkins participants had been diagnosed with life-threatening cancers.
About 80 percent of the 29 patients in the NYU study showed improvements six months after treatment. The NYU participants had advanced breast, gastrointestinal or blood cancers.
The findings are important because traditional psychotherapy, such as the use of antidepressants, isn't always effective in treating people with cancer, Griffiths and the other researchers said. It may take weeks or months for the drugs to work, and some drugs may have negative side effects, or can be addictive.
Scientists don't know exactly how psilocybin and other psychedelics work in the brain. They think they may affect serotonin, a chemical that controls mood and anxiety and is associated with depression.
Judith Goedeke, 63, a retired acupuncturist who lives in North Laurel, said she was one of the beneficiaries of the Johns Hopkins study. She had her left kidney and adrenal glands removed in 2003 after being diagnosed with kidney disease. After the surgery, she felt constantly tired and anxious.
At first, Goedeke was reluctant to try psilocybin because she remembered stories of people doing crazy things when high on psychedelics in the 1970s.
Like the other study participants, she was interviewed extensively and given surveys so researchers could gauge her mood, attitude about life and other emotional benchmarks. Each patient then went through two treatment sessions — the first with a low dose of psilocybin meant to act as a placebo and the second with a higher dose.
Researchers checked in again seven hours, five weeks and six months later.
Goedeke took the psilocybin in a Hopkins office decorated like a living room, complete with a fluffy white sofa. She remembers feeling very cold and shivering when she first got the pill. She also experienced a weird sensation around her heart and felt as if old fear was "peeling" off her body.
The second session was much more intense. She saw colorful images everywhere, coming and going very quickly. Then she felt as if her body lit up and she began to feel complete peace.
Goedeke said she was in a "bliss" for a year. Some of that feeling has subsided, but she still feels less anxious and less rundown than she did before the treatment.
"I feel so indebted to these brilliant, tender people at Hopkins," she said. "I have benefited enormously."
Johns Hopkins has also studied how psychedelics, combined with meditation, can enhance psychological well-being and spirituality in healthy people, and can be effective in smoking cessation.
Psilocybin is being studied as a treatment for alcoholism at the University of New Mexico and New York University, as a treatment for cocaine dependence at the University of Alabama at Birmingham, and as a novel antidepressant at Johns Hopkins and at Imperial College London.
Psychedelics were more widely studied in the 1950s and 1960s, until people began abusing the drugs and their use became stigmatized. The drugs were listed in the federal Controlled Substances Act as a Schedule 1 substance, the most dangerous designation, requiring researchers to get extra layers of approval from the Drug Enforcement Administration. This made the process more time-consuming and expensive.
The National Institutes of Health stopped funding studies, and pharmaceutical companies have not taken much interest in developing psychedelic drugs because they can't be patented.
Private funders, such as the Beckley Foundation and the Heffter Research Institute, have underwritten the costs of current studies. Heffter funded both the NYU and Johns Hopkins studies. The group said it is building off strong science from earlier decades.
"The research was shut down for social issues, but the potential for treating people was still there," said George Greer, Heffter's medical director. "The research did not stop for scientific reasons."
This should not be surprising. Basically, they have found exactly the same thing in end-life anxiety patients administered LSD. Both of these substances also affect real physical pain levels as well, which would have been awesome for my great aunt who passed away one year ago due to terminal cancer.
AFAIK though, they have been looking at this issue with depression and other diseases for quite some time now, and it seems like every time an article comes up for psychedelics and medicine the results are overwhelmingly positive.
For a few years now, i've truly believed that these substances are going to revolutionize how we deal with mental health issues in this country.
|
Moabfighter
Tam Fighter


Registered: 12/13/15
Posts: 2,710
|
Re: Johns Hopkins study on psilocybin and cancer patients. [Re: 404]
#23886095 - 12/01/16 10:28 PM (7 years, 1 month ago) |
|
|
I haven't really read the article, but I'm curious as to the rationale behind this.
Does mushroom stuff stay in your system long term? How does it treat depression from one dose, decently long term?
-------------------- KSSS And PE WBS.
|
DavidReishi
Mediocrity Extraordinaire


Registered: 10/07/15
Posts: 1,333
|
Re: Johns Hopkins study on psilocybin and cancer patients. [Re: Moabfighter]
#23886127 - 12/01/16 10:41 PM (7 years, 1 month ago) |
|
|
The effect of the experience is a lasting one. That's what's being said.
-------------------- Species found in the Bay area: P. allenii, P. cyanescens, P. ovoideocystidiata, P. stuntzii, P. azurescens
|
|